These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34858110)

  • 1. Scite.
    Brody S
    J Med Libr Assoc; 2021 Oct; 109(4):707-710. PubMed ID: 34858110
    [No Abstract]   [Full Text] [Related]  

  • 2. Pricing Mechanism Design for Centralized Pollutant Treatment with SME Alliances.
    Li Y; Huang B; Tao F
    Int J Environ Res Public Health; 2016 Jun; 13(6):. PubMed ID: 27338440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incentive pricing and cost recovery at the basin scale.
    Ward FA; Pulido-Velazquez M
    J Environ Manage; 2009 Jan; 90(1):293-313. PubMed ID: 18241978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plan choice, health insurance cost and premium sharing.
    Kosteas VD; Renna F
    J Health Econ; 2014 May; 35():179-88. PubMed ID: 24709039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus in context: Scite.ai tracks positive and negative citations for COVID-19 literature.
    Khamsi R
    Nature; 2020 May; ():. PubMed ID: 32358556
    [No Abstract]   [Full Text] [Related]  

  • 6. Consumers Buy Lower-Cost Plans On Covered California, Suggesting Exposure To Premium Increases Is Less Than Commonly Reported.
    Gabel JR; Arnold DR; Fulton BD; Stromberg ST; Green M; Whitmore H; Scheffler RM
    Health Aff (Millwood); 2017 Jan; 36(1):8-15. PubMed ID: 28069841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
    Ooms G; Forman L; Williams OD; Hill PS
    BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awakening consumer stewardship of health benefits: prevalence and differentiation of new health plan models.
    Rosenthal M; Milstein A
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1055-70. PubMed ID: 15230911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Employer contribution and premium growth in health insurance.
    Liu Y; Jin GZ
    J Health Econ; 2015 Jan; 39():228-47. PubMed ID: 25241905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Medicare plan choices: are beneficiaries more influenced by premiums or benefits?
    Jacobs PD; Buntin MB
    Am J Manag Care; 2015 Jul; 21(7):498-504. PubMed ID: 26247740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical Reference Pricing: Does It Have a Future in the U.S.?
    Robinson JC
    Issue Brief (Commonw Fund); 2018 Sep; 2018():1-6. PubMed ID: 30199167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing Impacts Of Market Concentration On Affordable Care Act Marketplace Premiums.
    Scheffler RM; Arnold DR; Fulton BD; Glied SA
    Health Aff (Millwood); 2016 May; 35(5):880-8. PubMed ID: 27140995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in county-level costs between traditional medicare and medicare advantage have implications for premium support.
    Biles B; Casillas G; Guterman S
    Health Aff (Millwood); 2015 Jan; 34(1):56-63. PubMed ID: 25561644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pricing strategies, the strength of bidding intentions, and online auction performance: a cross-cultural study.
    Peng YS; Jan LT
    Cyberpsychol Behav; 2009 Oct; 12(5):523-8. PubMed ID: 19817564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entropy-based financial asset pricing.
    Ormos M; Zibriczky D
    PLoS One; 2014; 9(12):e115742. PubMed ID: 25545668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tiered formularies and reference pricing policies: a systematic review.
    Morgan S; Hanley G; Greyson D
    Open Med; 2009; 3(3):e131-9. PubMed ID: 21603047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference Pricing in Germany: Implications for U.S. Pharmaceutical Purchasing.
    Robinson JC; Panteli D; Ex P
    Issue Brief (Commonw Fund); 2019 Feb; 2019():1-8. PubMed ID: 30883061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premium copayments and the trade-off between wages and employer-provided health insurance.
    Lubotsky D; Olson CA
    J Health Econ; 2015 Dec; 44():63-79. PubMed ID: 26406873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.